These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30549404)

  • 1. Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.
    Al Raisi SI; Pouliopoulos J; Qian P; King P; Byth K; Barry MT; Swinnen J; Thiagalingam A; Kovoor P
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E105-E111. PubMed ID: 30549404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
    Vogel B; Kirchberger M; Zeier M; Stoll F; Meder B; Saure D; Andrassy M; Mueller OJ; Hardt S; Schwenger V; Strothmeyer A; Katus HA; Blessing E
    Clin Res Cardiol; 2014 Feb; 103(2):117-24. PubMed ID: 24126436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
    Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
    JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical and procedural determinants of catheter-based renal denervation.
    Ewen S; Ukena C; Lüscher TF; Bergmann M; Blankestijn PJ; Blessing E; Cremers B; Dörr O; Hering D; Kaiser L; Nef H; Noory E; Schlaich M; Sharif F; Sudano I; Vogel B; Voskuil M; Zeller T; Tzafriri AR; Edelman ER; Lauder L; Scheller B; Böhm M; Mahfoud F
    Cardiovasc Revasc Med; 2016; 17(7):474-479. PubMed ID: 27617388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symplicity multi-electrode radiofrequency renal denervation system feasibility study.
    Whitbourn R; Harding SA; Walton A
    EuroIntervention; 2015 May; 11(1):104-9. PubMed ID: 25982652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy.
    Tsioufis C; Papademetriou V; Dimitriadis K; Kasiakogias A; Kordalis A; Andrikou E; Milkas A; Liatakis I; Lau EO; Tousoulis D
    J Hum Hypertens; 2016 Nov; 30(11):714-719. PubMed ID: 26818805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension.
    Ott C; Schmid A; Toennes SW; Ditting T; Veelken R; Uder M; Schmieder RE
    EuroIntervention; 2015 May; 11(1):110-6. PubMed ID: 25982653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.